Company Overview and News

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

Headline News

AVXS / AveXis, Inc. / RA Capital Management, LLC - SCHEDULE 13G/A (Passive Investment)

2018-02-16 sec.gov
      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13G Under the Securities Exchange Act of 1934   (Amendment No. 2)*   AveXis, Inc.   (Name of Issuer)   Common Stock, par value $0.0001 per share   (Title of Class of Securities)   05366U100   (CUSIP Number)   December 31, 2017   (Date of Event Which Requires Filing of this Statement)   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:     x Rule 13d-1(b)   ¨ Rule 13d-1

AVXS / AveXis, Inc. / RA Capital Management, LLC - SCHEDULE 13G/A (Passive Investment)

2018-02-15 sec.gov
      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13G Under the Securities Exchange Act of 1934   (Amendment No. 2)*   AveXis, Inc.   (Name of Issuer)   Common Stock, par value $0.0001 per share   (Title of Class of Securities)   05366U100   (CUSIP Number)   December 31, 2017   (Date of Event Which Requires Filing of this Statement)   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:     x Rule 13d-1(b)   ¨ Rule 13d-1

AVXS / AveXis, Inc. / PBM Capital Investments, LLC - SC 13G/A (Passive Investment)

2018-02-13 sec.gov
    SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13G   Under the Securities Exchange Act of 1934 (Amendment No. 1 )*   AveXis, Inc. (Name of Issuer)   Common Stock (Title of Class of Securities)   05366U100 (CUSIP Number)    December 31, 2017 (Date of Event which Requires Filing of this Statement)   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   ¨  Rule 13d-1(b)     ¨  Rule 13d-1(c)     x  Rule 13d-1(d)   *The remainder of this

AVXS / AveXis, Inc. / PBM Capital Investments, LLC - SC 13G/A (Passive Investment)

2018-02-13 sec.gov
    SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13G   Under the Securities Exchange Act of 1934 (Amendment No. 1 )*   AveXis, Inc. (Name of Issuer)   Common Stock (Title of Class of Securities)   05366U100 (CUSIP Number)    December 31, 2017 (Date of Event which Requires Filing of this Statement)   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   ¨  Rule 13d-1(b)     ¨  Rule 13d-1(c)     x  Rule 13d-1(d)   *The remainder of this

AVXS / AveXis, Inc. / FMR LLC / Fidelity - 3G/A (Passive Investment)

2018-02-13 sec.gov
SCHEDULE 13G Amendment No. 2 AVEXIS INC COMMON STOCK Cusip #05366U100 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #05366U100 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 1,496,293 Item 6: 0 Item 7: 4,796,462 Item 8: 0 Item 9: 4,796,462 Item 11: 14.999% Item 12: HC Cusip #05366U100 Item 1: Reporting Person - Abigail P.

AVXS / AveXis, Inc. / FMR LLC / Fidelity - 3G/A (Passive Investment)

2018-02-13 sec.gov
SCHEDULE 13G Amendment No. 2 AVEXIS INC COMMON STOCK Cusip #05366U100 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #05366U100 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 1,496,293 Item 6: 0 Item 7: 4,796,462 Item 8: 0 Item 9: 4,796,462 Item 11: 14.999% Item 12: HC Cusip #05366U100 Item 1: Reporting Person - Abigail P.

Regenxbio: Bullish Thesis Strengthens And Catalysts On The Way

2018-02-12 seekingalpha
Shares have risen significantly since initially presenting the idea to readers and are in the red following my last update piece. (36-0)

AVXS / AveXis, Inc. / VANGUARD GROUP INC - 3G (Passive Investment)

2018-02-08 sec.gov
avexisinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Schedule 13G   Under the Securities Exchange Act of 1934 (Amendment No.: 0 )*       Name of issuer:  Avexis Inc     Title of Class of Securities:  Common Stock     CUSIP Number:  05366U100     Date of Event Which Requires Filing of this Statement: December 31, 2017   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   (X) Rule 13d-1(b)   ( 

AVXS / AveXis, Inc. / VANGUARD GROUP INC - 3G (Passive Investment)

2018-02-08 sec.gov
avexisinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Schedule 13G   Under the Securities Exchange Act of 1934 (Amendment No.: 0 )*       Name of issuer:  Avexis Inc     Title of Class of Securities:  Common Stock     CUSIP Number:  05366U100     Date of Event Which Requires Filing of this Statement: December 31, 2017   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   (X) Rule 13d-1(b)   ( 

ROTY Edition 1 Volume 76: How To Deal With Market Selloffs And Spring Cleaning For The Contenders List

2018-02-06 seekingalpha
Readers are encouraged to make their voices heard in my recent blog post if they haven´t already. (647-3)

ROTY Edition 1 Volume 75: The Future Of ROTY, Cascadian Acquired And Updates

2018-02-02 seekingalpha
I encourage readers to check out my recent blog post which goes into detail regarding changes to Seeking Alpha and consequently to ROTY. (539-1)

Your Daily Pharma Scoop: Achaogen Update, Seattle Genetics Acquires Cascadian, Vical Announces Restructuring

2018-02-01 seekingalpha
Market update: Good morning, fellow investors. After the 21% gains last year, NBI kicked off the New Year on a very positive note. On the final trading day of the first month of 2018, the index is already up more than 9%. The gains have been partly driven by strong performance in the broader market, which is up more than 6% this month. A more important driver has been solid deal-making activity, which is always a good indicator for market sentiment. (224-5)

AVXS / AveXis, Inc. 8-K (Current Report)

2018-01-30 sec.gov
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): January 30, 2018   AVEXIS, INC. (Exact name of registrant as specified in its charter)   Delaware (State or other jurisdiction of incorporation)   001-37693   90-1038273 (Commission File No.

Gene therapy stocks slammed after scientist reveals safety concerns - MarketWatch

2018-01-30 marketwatch
Solid Biosciences shares slide 10% as paper says animals suffered toxic crisis in gene therapy trial (82-0)

AVXS / AveXis, Inc. / BlackRock Inc. - 3G/A (Passive Investment)

2018-01-29 sec.gov
us05366u1007_012918.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 1) AVEXIS INC -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 05366U100 -------------------------------------------------------- (CUSIP Number) December 31, 2017 -------------------------------------------------------- (D


CUSIP: 05366U100